Variation in the risk of venous thromboembolism in people with colorectal cancer: A population-based cohort study from England

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 5, 2014, Pages 641-649

  Walker, A J ^a   West, J ^a   Card, T R ^a   Humes, D J ^a   Grainge, M J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chemotherapy; Colorectal cancer; Colorectal surgery; Incidence; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM; VENOUS THROMBOEMBOLISM; COLORECTAL NEOPLASMS; COMPLICATION; ENGLAND; FACTUAL DATABASE; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; DATABASES, FACTUAL; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84901218137     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12533     Document Type: Article

References (26)

1. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 2012; 9: 1.
2. Treasure T. On behalf of the Guideline Development Group. Venous Thromboembolism: Reducing the Risk. London, UK: National Institute for Clinical Excellence (NICE), 2010.
3. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: 227.
4. Khorana AA, Dalal MR, Lin J, Connolly GC. Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. Clinicoecon Outcomes Res 2013; 5: 101-8.
5. Hall IE, Andersen MS, Krumholz HM, Gross CP. Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol 2009; 9: 1-9.
6. Mandalà M, Barni S, Prins M, Labianca R, Tondini C, Russo L, Milesi A, Cremonesi M, Zaccanelli M, Regonesi C, Moro C, Falanga A. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 2010; 21: 871-6.
7. Cronin-Fenton DP, Sondergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sorensen HT. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010; 103: 947-53.
8. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24: 1112-18.
9. Choi S, Lee KW, Bang SM, Kim S, Lee JO, Kim YJ, Kim JH, Park YS, Kim DW, Kang SB, Kim JS, Oh D, Lee JS. Different characteristics and prognostic impact of deep vein thrombosis/pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients. Thromb Haemost 2011; 106: 1084-94.
10. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 2013; 119: 648-55.
11. Otten HB, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 2004; 164: 190-4.
12. Blom JW, Vanderschoot JPM, Oostindiër MJ, Osanto S, van der Meer FJM, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4: 529-35.
13. Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 2013; 49: 1404-13.
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edn. New York: Springer, 2010.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
16. Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RDT. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000; 49: 591-6.
17. Tagalakis V, Wharin C, Kahn SR. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Semin Thromb Hemost 2013; 39: 127-40.
18. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 13: 2189-204.
19. Cancer Research UK. http://wwwcancerresearchukorg/cancer-info/cancerstats/types/bowel/survival/. 2012. Accessed 1 October 2013.
20. PbR data assurance framework 2008/09. Key messages from year 2 of the National Clinical Coding Audit Programme. Audit Commission. 2009:1.
21. Kakkar AK, Cohen AT, Tapson VF, Bergmann J-F, Goldhaber SZ, Deslandes B, Huang W, Anderson FAJ, Investigators ftE. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE Survey): findings in surgical patients. Ann Surg 2010; 251: 330-8.
22. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375: 657-63.
23. Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009; 27: 4839-47.
24. Toledano TH, Kondal D, Kahn SR, Tagalakis V. The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res 2013; 131: 1-5.
25. Kanz R, Vukovich T, Vormittag R, Dunkler D, Ay C, Thaler J, Haselböck J, Scheithauer W, Zielinski C, Pabinger I. Thrombosis risk and survival in cancer patients with elevated C-reactive protein. J Thromb Haemost 2011; 9: 57-63.
26. Verheijen P, Stevenson AL, Stitz R, Clark D, Clark A, Lumley J. Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery. Int J Colorectal Dis 2011; 26: 755-9.